Pulse Biosciences, Inc.
PLSE
$17.29
-$0.45-2.54%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -26.95% | -16.87% | 6.24% | 16.63% | 27.85% |
| Total Depreciation and Amortization | -2.40% | -3.55% | -6.18% | -9.54% | -10.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 88.94% | 72.74% | -26.34% | -36.77% | -48.07% |
| Change in Net Operating Assets | 221.88% | 143.27% | -82.25% | -188.24% | 120.67% |
| Cash from Operations | -9.99% | 0.71% | -3.13% | 4.58% | 29.72% |
| Capital Expenditure | -3.31% | 3.36% | 36.71% | 45.96% | 69.83% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.31% | 3.36% | 36.71% | 45.96% | 69.83% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 200.00% | 200.00% | 100.00% |
| Issuance of Common Stock | 573.55% | 303.88% | -89.98% | 4.57% | 6.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4,583.33% | -3,600.00% | -5,480.00% | -- | -- |
| Cash from Financing | 572.08% | 303.05% | -96.19% | -78.48% | -79.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 539.21% | 252.57% | -174.07% | -146.38% | -151.57% |